RxDoctor Payments Data

Steven Mashburn, NP

Family · Pulaski, TNNPI 1942373717

Payments from drug & device makers

$754in general payments, 2019–2025

Across 40 payments — averaging $18.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$226
  • Lilly USA, LLC$135
  • Xeris Pharmaceuticals, Inc.$77
  • Medtronic$53
  • Irhythm Technologies, Inc.$46
  • Bayer$41
  • plus $177 from 9 others

What the payments were for

  • Food & beverage$754100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$754 in reported general payments places this provider in the 55th percentile of 6,706 family providers in Tennessee.

See all family providers in Tennessee

Medicare billing

Part B allowed, 2024
$52,156
Medicare patients
121
Services billed
1,043

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide49$54,894
EliquisApixaban43$40,198
MounjaroTirzepatide24$25,640
JardianceEmpagliflozin15$25,323
FarxigaDapagliflozin Propanediol14$20,814
JanuviaSitagliptin Phosphate13$16,961
LinzessLinaclotide11$6,620
Gabapentin143$1,668
Lantus SolostarInsulin Glargine,hum.Rec.Anlog11$1,144
Albuterol Sulfate HfaAlbuterol Sulfate46$1,137
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen64$1,132
Omeprazole65$929
Duloxetine Hcl34$917
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen53$893
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine11$833

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$15$54,89449 claims
PfizerEliquis$14$40,19843 claims
Lilly USA, LLCMounjaro$135$25,64024 claims
Boehringer IngelheimJardiance$35$25,32315 claims
AstraZenecaFarxiga$226$20,81414 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 6,706 family providers in Tennessee.

Other family in Pulaski

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →